Stock Information

Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc logo
Ticker Symbol: DNLI
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,536.05 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.84
Revenue (TTM): $0.02 M
Dividend Yield: N/A
ROE: -55.27%

Latest News

Key Financials

Financial data not available